At the molecular level, upregulation of miR-509-3p was found to potentiate the expression of RhoA with a concurrent decrease in the levels of epithelial marker E-Cadherin – genes critical to the EMT process of cancer progression. This evidence concerns the gene CDH1 and cancer.